Cleared Traditional

K222065 - Passeo-35 Xeo Peripheral Dilatation Cat...

K222065 is the FDA 510(k) clearance for Passeo-35 Xeo Peripheral Dilatation Cat... by Biotronik, Inc.. It is a Class 2 Cardiovascular device (product code LIT) cleared through the Traditional 510(k) pathway after a 218-day FDA review.

K222065 · Biotronik, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2023
Decision
218d
Days
Class 2
Risk

K222065 is an FDA 510(k) clearance for the Passeo-35 Xeo Peripheral Dilatation Catheter. Classified as Catheter, Angioplasty, Peripheral, Transluminal (product code LIT), Class II - Special Controls.

Submitted by Biotronik, Inc. (Lake Oswego, US). The FDA issued a Cleared decision on February 16, 2023 after a review of 218 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Biotronik, Inc. devices

Submission Details

510(k) Number K222065 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 13, 2022
Decision Date February 16, 2023
Days to Decision 218 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
93d slower than avg
Panel avg: 125d · This submission: 218d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LIT Catheter, Angioplasty, Peripheral, Transluminal
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - LIT Catheter, Angioplasty, Peripheral, Transluminal

All 238
Devices cleared under the same product code (LIT) and FDA review panel - the closest regulatory comparables to K222065.
Finesse™ Injectable PTA Balloon Dilatation Catheter
K230263 · Summa Therapeutics, LLC · May 2023
D·Kaptain PTA High Pressure Balloon Dilatation Catheter
K214009 · Dk Medical Technology Co., Ltd. · Apr 2023
Arise™ UHP Dilatation Catheter
K230191 · Creagh Medical, Ltd. · Mar 2023
Highlander™ 014 PTA Balloon Dilatation Catheter
K223177 · C.R. Bard, Inc. · Jan 2023
PTA Balloon Dilatation Catheter
K221245 · Kossel Medtech (Suzhou) Co., Ltd. · Dec 2022
ENROUTE Enflate Transcarotid RX Balloon Dilatation Catheter
K221414 · Silk Road Medical, Inc. · Sep 2022